WODC U.S.

Parexel will participate in the World Orphan Drug Congress USA 2026 (June 9–11, Boston), a congress that brings together leading pharmaceutical and biotech companies, regulators, payers, investors, patient advocates, and solution providers to accelerate orphan drug development and improve access to therapies for people living with rare diseases.  With more than 280 speakers and thematic tracks covering clinical development, regulation, pricing and reimbursement, next‑generation therapies, early access programs, digital health, and real‑world evidence, the event provides critical insights that shape strategic planning and trial design in rare conditions. 
     
Join Parexel at booth #213 and on stage as we showcase our scientific expertise and operational capabilities in rare and orphan drug research—an area where innovative trial approaches and strong cross‑stakeholder collaboration are essential.